Breaking News Instant updates and real-time market news.

2020-12-18 11:44:03 DUNE Dune Acquisition $0.00 / + (+0.00%) 11:44 12/18/20 12/18 11:44 12/18/20 11:44	Dune Acquisition opens for trade at $10.15, IPO priced at $10 Dune Acquisition priced of its upsized initial public offering of 15M units at a price of $10.00 per unit. The units are listed on Nasdaq and trade under the ticker symbol "DUNEU". After the securities comprising the units begin separate trading, the shares of class A common stock and warrants are expected to be listed on Nasdaq under the symbols "DUNE" and "DUNEW," respectively. Dune Acquisition was founded by its Chief Executive Officer, Carter Glatt. The company is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search for an initial business combination on companies within the technology sector, particularly companies pursuing a software as a service model. Cantor Fitzgerald is acting as sole book-runner and Needham as co-manager of the offering.

2020-12-18 11:44:03

DUNE

Dune Acquisition

$0.00 / + (+0.00%)

11:44

12/18/20

12/18

11:44

12/18/20

11:44

Dune Acquisition opens for trade at $10.15, IPO priced at $10

Dune Acquisition priced of its upsized initial public offering of 15M units at a price of $10.00 per unit. The units are listed on Nasdaq and trade under the ticker symbol "DUNEU". After the securities comprising the units begin separate trading, the shares of class A common stock and warrants are expected to be listed on Nasdaq under the symbols "DUNE" and "DUNEW," respectively. Dune Acquisition was founded by its Chief Executive Officer, Carter Glatt. The company is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search for an initial business combination on companies within the technology sector, particularly companies pursuing a software as a service model. Cantor Fitzgerald is acting as sole book-runner and Needham as co-manager of the offering.

TODAY'S FREE FLY STORIES

Hot Stocks	Air Canada to resume Boeing 737 MAX commercial operations on Feb. 1 » 13:11 01/18/21 01/18 13:11 01/18/21 13:11 ACDVF Air Canada $0.00 / + (+0.00%) , BA Boeing $204.29 / -5.6 (-2.67%) Air Canada (ACDVF) said… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ACDVF BA ACDVF Air Canada $0.00 / + (+0.00%) 12/23/20 Trudeau says Canada's suspension of passenger flights from UK extended 12/14/20 Chase, Air Canada, MasterCard to launch U.S. credit card BA Boeing $204.29 / -5.6 (-2.67%) 01/12/21 Boeing awarded $1.69B Air Force contract modification for KC-46 aircraft 01/12/21 Boeing reports 59 commercial airplane deliveries in Q4 01/12/21 Atlas Air orders four Boeing 747-8 Freighters 01/11/21 Boeing to provide six more solar arrays for International Space Station ACDVF BA ACDVF Air Canada $0.00 / + (+0.00%) 01/11/21 Cowen Air Canada upgraded to Outperform from Market Perform at Cowen 01/08/21 BofA Air Canada upgraded to Buy from Neutral at BofA 01/05/21 RBC Capital Air Canada price target lowered to C$27 from C$30 at RBC Capital 01/04/21 Scotiabank Air Canada price target lowered to C$29 from C$30 at Scotiabank BA Boeing $204.29 / -5.6 (-2.67%) 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird 01/04/21 Bernstein Bernstein downgrades Boeing to Underperform on worsening 787 outlook 01/04/21 Bernstein Boeing downgraded to Underperform from Market Perform at Bernstein BA BA Boeing $204.29 / -5.6 (-2.67%) 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) 10/27/20 Notable companies reporting before tomorrow's open 10/27/20 Notable companies reporting before tomorrow's open 07/29/20 Boeing reports Q2 core EPS ($4.79), consensus ($2.54) ACDVF BA ACDVF Air Canada $0.00 / + (+0.00%) 11/05/20 Canada close to aid package for airlines, Reuters reports BA Boeing $204.29 / -5.6 (-2.67%) 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports 12/31/20 U.S. amends duties on EU goods in Airbus, Boeing dispute, Bloomberg says BA BA Boeing $204.29 / -5.6 (-2.67%) 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/27/21 Boeing - BA BA BA Boeing $204.29 / -5.6 (-2.67%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th
Initiation	Tesco reinstated with a Buy at Goldman Sachs » 13:09 01/18/21 01/18 13:09 01/18/21 13:09 TSCDY Tesco $0.00 / + (+0.00%) Goldman Sachs analyst Rob… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research TSCDY Tesco $0.00 / + (+0.00%) 11/02/20 PepsiCo elects Dave Lewis to Board of Directors TSCDY Tesco $0.00 / + (+0.00%) 01/04/21 Barclays Tesco reinstated with an Overweight at Barclays 01/04/21 Barclays Tesco reinstated with an Overweight at Barclays 12/17/20 Morgan Stanley Tesco price target raised to 287 GBp from 276 GBp at Morgan Stanley 10/23/20 Kepler Cheuvreux Tesco downgraded to Hold from Buy at Kepler Cheuvreux
Hot Stocks	Biohaven's troriluzole did not differentiate from placebo in Alzheimer's trial » 13:06 01/18/21 01/18 13:06 01/18/21 13:06 BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) Biohaven Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 01/07/21 Biohaven Pharmaceutical acquires Kleo Pharmaceuticals, forms Biohaven Labs 01/04/21 Biohaven Pharmaceutical starts Phase 3 Trial of troriluzole in OCD 12/16/20 Biohaven's rimegepant shows efficacy and safety for migraine in Phase 3 trial 11/23/20 BioShin announces first patients enrolled in BHV3000-310 study in China, Korea BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 12/29/20 Cantor Fitzgerald Biohaven price target raised to $115 from $109 at Cantor Fitzgerald 12/23/20 Piper Sandler Piper 'comfortable' owning Biohaven shares into Alzheimer's readout 12/15/20 H.C. Wainwright Biohaven Pharmaceutical initiated with a Buy at H.C. Wainwright 12/07/20 SVB Leerink Biohaven Pharmaceutical price target raised to $120 from $85 at SVB Leerink BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 11/09/20 Biohaven Pharmaceutical reports Q3 adj. EPS ($2.67), consensus ($2.89) 08/10/20 Biohaven Pharmaceutical reports Q2 non-GAAP EPS ($2.55), consensus ($2.61) 29 Jan 01/21/21 Biotechnology
Hot Stocks	Granite announces $20M contact by California Department of Transportation » 13:02 01/18/21 01/18 13:02 01/18/21 13:02 GVA Granite $33.21 / -0.7 (-2.06%) Granite announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GVA Granite $33.21 / -0.7 (-2.06%) 01/14/21 Granite Construction awarded CMAR contract by Tucson International Airport 01/12/21 Granite JV awarded $125M Bay City Bridges Project in Michigan 01/04/21 Granite Construction opens new Solari aggregate plant in Arvin, CA 12/07/20 Granite Construction awarded $101M contract in Southern California GVA Granite $33.21 / -0.7 (-2.06%) 06/25/20 DA Davidson Granite Construction price target lowered to $17 from $30 at DA Davidson GVA Granite $33.21 / -0.7 (-2.06%) 08/10/20 Granite reports $463.6M of available liquidity at end of Q2
Hot Stocks	Equinox announces positive drill results from Piaba Underground target » 13:00 01/18/21 01/18 13:00 01/18/21 13:00 EQX Equinox Gold $10.03 / -0.455 (-4.34%) Equinox Gold announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options EQX Equinox Gold $10.03 / -0.455 (-4.34%) 01/11/21 Equinox Gold produces 136,400 oz of gold in Q4 12/23/20 Equinox Gold begins staged restart at Los Filos Mine in Mexico 12/16/20 Equinox Gold to acquire Premier Gold Mines, to spin out i-80 Gold 11/20/20 Equinox Gold announces resumption of blockade at Los Filos Mine in Mexico EQX Equinox Gold $10.03 / -0.455 (-4.34%) 01/12/21 BMO Capital Equinox Gold price target raised to C$22.50 from C$22 at BMO Capital 01/11/21 National Bank Equinox Gold price target lowered to C$17 from C$18 at National Bank 01/11/21 Scotiabank Equinox Gold price target lowered to C$18.25 from C$19.25 at Scotiabank 12/21/20 BMO Capital Equinox Gold price target raised to C$22 from C$21.50 at BMO Capital EQX Equinox Gold $10.03 / -0.455 (-4.34%) 12/03/20 Unusual call flow in option market yesterday 11/23/20 Largest borrow rate increases among liquid names

Hot Stocks	AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer » 12:58 01/18/21 01/18 12:58 01/18/21 12:58 AZN AstraZeneca $51.35 / +0.05 (+0.10%) AstraZeneca and Daiichi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $51.35 / +0.05 (+0.10%) 01/15/21 Aveo Pharmaceuticals announces results from portion of DEDUCTIVE trial 01/15/21 AstraZeneca's Imfinzi approved in E.U. and U.K. for additional dosing in NSCLC 01/12/21 AstraZeneca to present new data from lung cancer portfolio at WCLC 01/12/21 AstraZeneca, Recombinetics announce research collaboration on NF1 AZN AstraZeneca $51.35 / +0.05 (+0.10%) 01/15/21 Berenberg AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Deutsche Bank AstraZeneca initiated with a Buy at Deutsche Bank 01/08/21 Raymond James Alexion downgraded to Market Perform from Outperform at Raymond James AZN AstraZeneca $51.35 / +0.05 (+0.10%) 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year 07/30/20 AstraZeneca backs FY20 mid- to high-teens percentage increase in core EPS 07/30/20 AstraZeneca reports Q2 core EPS 96c, up 31% at CER AZN AstraZeneca $51.35 / +0.05 (+0.10%) 01/17/21 Pakistan approves AstraZeneca COVID vaccine for emergency use, Reuters says 01/15/21 AstraZeneca's COVISHIELD vaccine approved by Nepal, Reuters reports 01/03/21 AstraZeneca/Oxford COVID vaccine authorized by India, WSJ reports 12/30/20 U.S. EUA for AstraZeneca's COVID vaccine likely in April, Reuters reports AZN AstraZeneca $51.35 / +0.05 (+0.10%) 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 02/20/21 PDUFA Date for Tagrisso (Osimertinib) 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $51.35 / +0.05 (+0.10%) 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th 12/28/20 Unusually active option classes on open December 28th 12/14/20 AstraZeneca call volume above normal and directionally bullish
Hot Stocks	Quest enters agreement with CDC for genomic sequencing of Covid variants » 12:56 01/18/21 01/18 12:56 01/18/21 12:56 DGX Quest Diagnostics $124.35 / -0.56 (-0.45%) Quest Diagnostics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DGX Quest Diagnostics $124.35 / -0.56 (-0.45%) 01/11/21 Akouos, Blueprint Genetics announce Resonate program 12/22/20 Quest Diagnostics, Hackensack Meridian Health to partner on laboratory services 12/21/20 Q2 Solutions teams with Adaptive Biotechnologies to market immunoSEQ Assay 12/17/20 Quest Diagnostics, The Commons Project announce collaboration DGX Quest Diagnostics $124.35 / -0.56 (-0.45%) 12/17/20 Morgan Stanley Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown 12/17/20 Morgan Stanley Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley 10/26/20 Mizuho Quest Diagnostics price target raised to $149 from $144 at Mizuho 10/21/20 Argus Quest Diagnostics upgraded to Buy from Hold at Argus DGX Quest Diagnostics $124.35 / -0.56 (-0.45%) 12/16/20 Quest Diagnostics raises FY20 adj. EPS view to at least $10.75 from $9.00-$10.00 10/22/20 Quest Diagnostics raises FY20 adj. EPS view to $9.00-$10.00 from $7.50-$9.00 10/22/20 Quest Diagnostics reports Q3 adj. EPS $4.31, consensus $3.73 10/21/20 Notable companies reporting before tomorrow's open DGX Quest Diagnostics $124.35 / -0.56 (-0.45%) 07/22/20 LabCorp: COVID spreading faster than it can add testing capacity, CNBC reports 07/21/20 Quest exec: 'No way' COVID testing capacity can cope with flu season, FT reports DGX Quest Diagnostics $124.35 / -0.56 (-0.45%) 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 12/16/20 Fly Intel: Pre-market Movers 10/26/20 Fly Insider: Selecta, Netflix among week's notable insider trades 10/22/20 Fly Intel: Pre-market Movers 02/04/21 Quest Diagnostics - DGX DGX Quest Diagnostics $124.35 / -0.56 (-0.45%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/16/20 Early notable gainers among liquid option names on October 16th 08/20/20 Early notable gainers among liquid option names on August 20th
Hot Stocks	Reliance Steel promotes Karla Lewis to President, names Arthur Ajemyan CFO » 12:46 01/18/21 01/18 12:46 01/18/21 12:46 RS Reliance Steel $127.66 / -4.16 (-3.16%) Reliance Steel &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RS Reliance Steel $127.66 / -4.16 (-3.16%) 07/23/20 Reliance Steel sees Q3 demand improving "slightly" over Q2 RS Reliance Steel $127.66 / -4.16 (-3.16%) 01/08/21 Deutsche Bank Reliance Steel downgraded to Hold from Buy at Deutsche Bank 01/08/21 Deutsche Bank Reliance Steel downgraded to Hold from Buy at Deutsche Bank 10/23/20 Fly Intel: Top five analyst upgrades 10/23/20 BofA Reliance Steel upgraded to Buy from Neutral at BofA RS Reliance Steel $127.66 / -4.16 (-3.16%) 10/22/20 Reliance Steel sees Q4 adjusted EPS $1.30-$1.40, consensus $1.68 10/22/20 Reliance Steel reports Q3 adjusted EPS $1.87, consensus $1.50 07/23/20 Reliance Steel reports Q2 non-GAAP EPS $ 1.36 consensus 40c
Hot Stocks	Zomedica regained compliance with NYSE American's listing standards » 12:44 01/18/21 01/18 12:44 01/18/21 12:44 ZOM Zomedica $0.98 / -0.0298 (-2.97%) Zomedica said in a letter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate ZOM Zomedica $0.98 / -0.0298 (-2.97%) 01/04/21 Zomedica names Robert Cohen as CEO, effective January 1 12/15/20 Zomedica to remain domiciled in Canada 11/13/20 Zomedica expects to begin commercialization of TRUFORMA on March 30, 2021 10/26/20 Zomedica interim CEO urges shareholders to vote for domestication proposal ZOM Zomedica $0.98 / -0.0298 (-2.97%) 06/17/20 H.C. Wainwright Zomedica price target lowered to 50c from 65c at H.C. Wainwright 02 Jul
Hot Stocks	Tronox 'very optimistic' about short-, long-term potential for TiO2 » 12:40 01/18/21 01/18 12:40 01/18/21 12:40 TROX Tronox $14.68 / -0.375 (-2.49%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TROX Tronox $14.68 / -0.375 (-2.49%) 12:38 Today Tronox intends to increase annualized dividend to 32c from 28c 12:37 Today Tronox announces termination of TiZir Titanium and Iron acquisition agreement 01/04/21 CMA to open investigation into Tronox acquisition of Eramet TTI business 12/27/20 Tronox appoints John Romano, Jean-Francois Turgeon co-CEOs on interim basis TROX Tronox $14.68 / -0.375 (-2.49%) 12/28/20 Alembic Global Dow Inc., Olin, Tronox named among 2021 chemical top picks at Alembic Global 06/05/20 JPMorgan JPMorgan calls Tronox 'the forgotten cyclical' 05/08/20 SunTrust Tronox price target lowered to $12 from $20 at SunTrust TROX Tronox $14.68 / -0.375 (-2.49%) 12:39 Today Tronox sees Q4 revenue $783M, consensus $696.29M

Earnings	Tronox sees Q4 revenue $783M, consensus $696.29M » 12:39 01/18/21 01/18 12:39 01/18/21 12:39 TROX Tronox $14.68 / -0.375 (-2.49%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research TROX Tronox $14.68 / -0.375 (-2.49%) 12:38 Today Tronox intends to increase annualized dividend to 32c from 28c 12:37 Today Tronox announces termination of TiZir Titanium and Iron acquisition agreement 01/04/21 CMA to open investigation into Tronox acquisition of Eramet TTI business 12/27/20 Tronox appoints John Romano, Jean-Francois Turgeon co-CEOs on interim basis TROX Tronox $14.68 / -0.375 (-2.49%) 12/28/20 Alembic Global Dow Inc., Olin, Tronox named among 2021 chemical top picks at Alembic Global 06/05/20 JPMorgan JPMorgan calls Tronox 'the forgotten cyclical' 05/08/20 SunTrust Tronox price target lowered to $12 from $20 at SunTrust
Hot Stocks	Tronox intends to increase annualized dividend to 32c from 28c » 12:38 01/18/21 01/18 12:38 01/18/21 12:38 TROX Tronox $14.68 / -0.375 (-2.49%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research TROX Tronox $14.68 / -0.375 (-2.49%) 12:37 Today Tronox announces termination of TiZir Titanium and Iron acquisition agreement 01/04/21 CMA to open investigation into Tronox acquisition of Eramet TTI business 12/27/20 Tronox appoints John Romano, Jean-Francois Turgeon co-CEOs on interim basis TROX Tronox $14.68 / -0.375 (-2.49%) 12/28/20 Alembic Global Dow Inc., Olin, Tronox named among 2021 chemical top picks at Alembic Global 06/05/20 JPMorgan JPMorgan calls Tronox 'the forgotten cyclical' 05/08/20 SunTrust Tronox price target lowered to $12 from $20 at SunTrust
Hot Stocks	Tronox announces termination of TiZir Titanium and Iron acquisition agreement » 12:37 01/18/21 01/18 12:37 01/18/21 12:37 TROX Tronox $14.68 / -0.375 (-2.49%) Tronox Holdings released… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research TROX Tronox $14.68 / -0.375 (-2.49%) 01/04/21 CMA to open investigation into Tronox acquisition of Eramet TTI business 12/27/20 Tronox appoints John Romano, Jean-Francois Turgeon co-CEOs on interim basis TROX Tronox $14.68 / -0.375 (-2.49%) 12/28/20 Alembic Global Dow Inc., Olin, Tronox named among 2021 chemical top picks at Alembic Global 06/05/20 JPMorgan JPMorgan calls Tronox 'the forgotten cyclical' 05/08/20 SunTrust Tronox price target lowered to $12 from $20 at SunTrust
Hot Stocks	Grifols to begin clinical trial in Spain for new COVID-19 drug » 12:34 01/18/21 01/18 12:34 01/18/21 12:34 GRFS Grifols $19.10 / -0.05 (-0.26%) Grifols announced it will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GRFS Grifols $19.10 / -0.05 (-0.26%) 11/13/20 Soros takes stake in Palantir, exits TransDigm position 11/09/20 Grifols acquires remaining 49% of Goetech for $60.2M 10/09/20 Grifols begins anti-SARS-CoV-2 hyperimmune globulin trial 08/24/20 Grifols jumps after FDA issues emergency use authorization for plasma GRFS Grifols $19.10 / -0.05 (-0.26%) 01/13/21 Morgan Stanley Grifols price target lowered to EUR 31 from EUR 32 at Morgan Stanley 12/09/20 Morgan Stanley Grifols price target raised to EUR 32 from EUR 31 at Morgan Stanley 11/06/20 Morgan Stanley Grifols price target raised to EUR 31 from EUR 30 at Morgan Stanley 10/30/20 Berenberg Grifols price target lowered to EUR 24.50 from EUR 25.30 at Berenberg GRFS Grifols $19.10 / -0.05 (-0.26%) 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports GRFS Grifols $19.10 / -0.05 (-0.26%) 08/24/20 Fly Intel: Wall Street's top stories for Monday 08/24/20 Fly Intel: Wall Street's top stories at midday 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers
Hot Stocks	New Oriental Education names CFO Zhihui Yang Executive President » 12:31 01/18/21 01/18 12:31 01/18/21 12:31 EDU New Oriental Education $172.75 / -3.255 (-1.85%) New Oriental Education… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Periodicals Events EDU New Oriental Education $172.75 / -3.255 (-1.85%) 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 12/28/20 Citi Citi keeps 'long-term positive stance' on New Oriental Education 11/30/20 CLSA New Oriental Education weakness a buying opportunity, says CLSA 11/25/20 Morgan Stanley OneSmart downgraded to Equal Weight on margin pressure at Morgan Stanley EDU New Oriental Education $172.75 / -3.255 (-1.85%) 10/13/20 New Oriental Education sees Q2 revenue $863.7M-$887.3M, consensus $860.5M 10/13/20 New Oriental Education reports Q1 EPS $1.15, consensus $1.01 07/28/20 New Oriental Education sees Q3 revenue $911.2M-$953.5M, consensus $1.09B 07/28/20 New Oriental Education reports Q2 EPS 30c, consensus 35c EDU New Oriental Education $172.75 / -3.255 (-1.85%) 08/07/20 Citon says authorities given info to end GSX Techedu 'charade' 01/22/21 New Oriental Education - EDU

Hot Stocks	Partner says lawsuit against subsidiary recognized as class action » 12:30 01/18/21 01/18 12:30 01/18/21 12:30 PTNR Partner Communications $5.06 / -0.1 (-1.94%) Partner Communications… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research PTNR Partner Communications $5.06 / -0.1 (-1.94%) 11/18/20 Partner Communications announces consideration of fiber optics transaction PTNR Partner Communications $5.06 / -0.1 (-1.94%) 12/02/20 Barclays Partner Communications price target raised to ILS 1,900 at Barclays
Hot Stocks	Guardant Health announces partnership with Vall d'Hebron Institute of Oncology » 12:29 01/18/21 01/18 12:29 01/18/21 12:29 GH Guardant Health $159.27 / +1.77 (+1.12%) Guardant Health and Vall… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly GH Guardant Health $159.27 / +1.77 (+1.12%) 01/11/21 Guardant Health to launch Guardant Reveal colon cancer liquid biopsy test 12/11/20 Guardant Health names Michael Bell as new CFO, succeeding Derek Bertocci 11/05/20 Guardant Health not providing FY20 guidance 10/15/20 Aetna says Guardant360CDx testing panel considered 'not medically necessary' GH Guardant Health $159.27 / +1.77 (+1.12%) 01/14/21 Canaccord Natera price target raised to $125 from $112 at Canaccord 01/12/21 Canaccord Guardant Health price target raised to $170 from $145 at Canaccord 01/11/21 Fly Intel: Top five analyst initiations 01/11/21 Stifel Guardant Health initiated with a Buy at Stifel GH Guardant Health $159.27 / +1.77 (+1.12%) 11/05/20 Guardant Health reports Q3 GAAP EPS (78c), consensus (38c) 08/06/20 Guardant Health reports Q2 EPS (57c), consensus (38c) 07 Oct 02 Jun GH Guardant Health $159.27 / +1.77 (+1.12%) 10/06/20 Fly Intel: After-Hours Movers
Hot Stocks	Calliditas says Phase 1 setanaxib trial shows favorable pharmacokinetic profile » 12:28 01/18/21 01/18 12:28 01/18/21 12:28 CALT Calliditas Therapeutics $30.55 / -0.61 (-1.96%) Genkyotex SA, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events CALT Calliditas Therapeutics $30.55 / -0.61 (-1.96%) 11/09/20 Calliditas Therapeutics says Part A of NefIgArd trial met its primary objective CALT Calliditas Therapeutics $30.55 / -0.61 (-1.96%) 07/01/20 Citi Calliditas Therapeutics initiated with a Buy at Citi 06/30/20 Jefferies Calliditas Therapeutics initiated with a Buy at Jefferies 06/30/20 Stifel Calliditas Therapeutics initiated with a Buy at Stifel 05 Jun 01/20/21 Calliditas Therapeutics
Hot Stocks	Celyad reports 10.6 months median overall survival in Phase 1 alloSHRINK trial » 12:25 01/18/21 01/18 12:25 01/18/21 12:25 CYAD Celyad $8.30 / -0.02 (-0.24%) Celyad Oncology announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CYAD Celyad $8.30 / -0.02 (-0.24%) 01/07/21 Celyad enters equity purchase agreement for up to $40M with Lincoln Park Capital 12/15/20 Celyad successfully doses first patient in CYAD-101 phase 1 trial 12/07/20 Celyad provides update on allogeneic, autologous CAR T programs 12/04/20 Celyad doses first patient in IMMUNICY-1 trial of CYAD-211 CYAD Celyad $8.30 / -0.02 (-0.24%) 12/08/20 H.C. Wainwright Celyad price target lowered to $18 from $22 at H.C. Wainwright 03/26/20 Wells Fargo Celyad price target lowered to $20 from $44 at Wells Fargo 03/25/20 H.C. Wainwright Celyad price target lowered to $37 from $43 at H.C. Wainwright
Upgrade	Shoprite upgraded to Neutral from Sell at Goldman Sachs » 12:19 01/18/21 01/18 12:19 01/18/21 12:19 SRGHY Shoprite $0.00 / + (+0.00%) Goldman Sachs analyst… Goldman Sachs analyst Mikhail Butkov upgraded Shoprite to Neutral from Sell with a price target of ZAR 139, up from ZAR 126. The analyst cites valuation for the upgrade following the stock's underperformance. Butkov nos longer see downside to consensus estimates and now has a slightly more constructive view on the profitability recovery in broader Africa. ShowHide Related Items >><< Street Research SRGHY Shoprite $0.00 / + (+0.00%) 09/02/20 HSBC Shoprite upgraded to Buy from Hold at HSBC

General news	FX Summary: The dollar put in a firming session » 10:55 01/18/21 01/18 10:55 01/18/21 10:55 FX Summary: The dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	Klepierre downgraded to Underperform from Neutral at BofA » 09:43 01/18/21 01/18 09:43 01/18/21 09:43 KLPEF Klepierre $0.00 / + (+0.00%) BofA analyst Marc Mozzi… BofA analyst Marc Mozzi downgraded Klepierre to Underperform from Neutral. The analyst is "cautiously optimistic" about the outlook for European real estate in 2021. ShowHide Related Items >><< Street Research KLPEF Klepierre $0.00 / + (+0.00%) 01/15/21 JPMorgan Klepierre price target lowered to EUR 20 from EUR 22 at JPMorgan 12/10/20 Goldman Sachs Klepierre upgraded to Neutral from Sell at Goldman Sachs 11/20/20 RBC Capital Klepierre price target raised to EUR 25 from EUR 23 at RBC Capital 11/09/20 HSBC Klepierre upgraded to Buy from Hold at HSBC
Upgrade	Great Portland Estates upgraded to Neutral from Underperform at BofA » 09:43 01/18/21 01/18 09:43 01/18/21 09:43 GPEAF Great Portland Estates $0.00 / + (+0.00%) BofA analyst Marc Mozzi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GPEAF Great Portland Estates $0.00 / + (+0.00%) 01/05/21 Morgan Stanley Great Portland Estates downgraded to Equal Weight from Overweight at Morgan Stanley 10/20/20 BofA Great Portland Estates downgraded to Underperform from Neutral at BofA 06/25/20 HSBC Great Portland Estates upgraded to Hold from Reduce at HSBC 06/04/20 Barclays Great Portland Estates price target lowered to 570 GBp from 740 GBp at Barclays
Upgrade	Shurgard Self Storage upgraded to Buy from Neutral at BofA » 09:42 01/18/21 01/18 09:42 01/18/21 09:42 SSSAF Shurgard Self Storage $0.00 / + (+0.00%) BofA analyst Marc Mozzi… BofA analyst Marc Mozzi upgraded Shurgard Self Storage to Buy from Neutral. The analyst is "cautiously optimistic" about the outlook for European real estate in 2021. ShowHide Related Items >><< Street Research SSSAF Shurgard Self Storage $0.00 / + (+0.00%) 11/04/20 JPMorgan Shurgard Self Storage upgraded to Overweight from Neutral at JPMorgan 09/03/20 Stifel Shurgard Self Storage initiated with a Hold at Stifel 07/30/20 JPMorgan Shurgard Self Storage price target lowered to EUR 27 from EUR 32 at JPMorgan
Upgrade	Gecina upgraded to Buy from Neutral at BofA » 09:42 01/18/21 01/18 09:42 01/18/21 09:42 GECFF Gecina $0.00 / + (+0.00%) BofA analyst Marc Mozzi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GECFF Gecina $0.00 / + (+0.00%) 01/05/21 Morgan Stanley Gecina price target raised to EUR 130 from EUR 120 at Morgan Stanley 09/11/20 HSBC Gecina upgraded to Buy from Hold at HSBC 09/03/20 Morgan Stanley Gecina price target lowered to EUR 120 from EUR 125 at Morgan Stanley 07/28/20 Barclays Gecina price target raised to EUR 131 from EUR 130 at Barclays

Events

Earnings calls, analyst events, roadshows and more

SAIC
Tomorrow at 00:00

SAIC - SAIC Conference Calls
RMYHY
Tomorrow at 00:00

Clinical Excellence in the Acute Care Sector Conferences

Webinar
Tomorrow at 00:00

Asia ESG /Solar & Wind Virtual Seminar Conferences

Virtual Seminar
XBIO ...
Tomorrow at 00:00

17th Annual Small & Microcap Virtual Investor Conference Conferences

Virtual Conference
BOWFF ...
Tomorrow at 00:00

16th Annual Scotiabank Canadian Multi-Family REIT Panel Conferences

Virtual Property Tour
Tomorrow at 00:00

Thailand C-Suite Virtual Corporate Day Conferences

Virtual Conference
Tomorrow at 00:00

Winter Restaurant, Foodservice, Gaming, Lodging & Leisure Virtual Summit Conferences

Virtual Summit
SAIC
Tomorrow at 00:00

SAIC Firm Sponsored Meetings

Virtual Meeting
TCOM
Tomorrow at 00:00

Trip.com Group Firm Sponsored Meetings

Virtual Meeting
NEON
Tomorrow at 00:00

Neonode Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $16.00-18.00 15.647M Shares
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares
Fri	No deals

View All Syndicate Announcements »

Dune Acquisition opens for trade at $10.15, IPO priced at $10

TODAY'S FREE FLY STORIES

Get Full Fly Access